Logo AcedrA 2.png
TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region
18. März 2024 12:19 ET | AcedrA BioPharmaceuticals; TaiMed Biologics
TaiMed and AcedrA officially signed an exclusive license, commercialization, and distribution agreement for Trogarzo in the MENA region.
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast featuring Tryp Therapeutics Inc. Chairman and CEO Greg McKee
17. Juni 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- (via InvestorWire) InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
logo.jpg
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
18. Mai 2021 16:05 ET | Processa Pharmaceuticals, Inc.
HANOVER, MD., May 18, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve...
Medium Juva Logo (002).png
Juva Life Unifies and Accelerates Brand Marketing Plans
14. Januar 2021 04:30 ET | Juva Life Inc.
VANCOUVER, British Columbia, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTC: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a premier California based...